What Should Pharmacists Advise Patients Taking Aspirin and Rivaroxaban, if Approved?

Conference|European Society of Cardiology

In this clip, Deepak Bhatt, MD, discusses how pharmacists should counsel patients taking aspirin and rivaroxaban, if approved.

In this clip, Deepak Bhatt, MD, discusses how pharmacists should counsel patients taking aspirin and rivaroxaban, if approved.

Related Videos
Patient with cancer receiving an infusion | Image credit: RFBSIP - stock.adobe.com
Burnout illustration | Image credit: Vikky Mir - stock.adobe.com
Stack of files and gavel | Image credit: BillionPhotos.com - stock.adobe.com
Public Health Matters podcast logo
Cancer patient with IV | Image credit: Monkey Business - stock.adobe.com
Capitol Building | Image credit: lazyllama - stock.adobe.com
Smiling Asian female pharmacist working in chemist shop or pharmacy | Image Credit: Atstock Productions - stock.adobe.com
sofiko14 / stock.adobe.com
Related Content

Expert: Diversity and Inclusion Efforts Must Move Beyond Passive Research to Action

March 24th 2023

Independent Rx Forum - Five Trends in Community Pharmacy

March 22nd 2023

Immunotherapies Changing the Way Relapsed/Refractory Settings Are Managed

March 24th 2023

On The Shelf - Career Wellness

March 16th 2023

FDA Approves Rezafungin Injection for the Treatment of Candidemia, Invasive Candidiasis

March 24th 2023

Pharmacists are Essential in Curbing the Opioid Crisis in Older People

March 24th 2023

Expert: Diversity and Inclusion Efforts Must Move Beyond Passive Research to Action

March 24th 2023

Independent Rx Forum - Five Trends in Community Pharmacy

March 22nd 2023

Immunotherapies Changing the Way Relapsed/Refractory Settings Are Managed

March 24th 2023

On The Shelf - Career Wellness

March 16th 2023

FDA Approves Rezafungin Injection for the Treatment of Candidemia, Invasive Candidiasis

March 24th 2023

Pharmacists are Essential in Curbing the Opioid Crisis in Older People

March 24th 2023

Expert: Diversity and Inclusion Efforts Must Move Beyond Passive Research to Action

March 24th 2023

Independent Rx Forum - Five Trends in Community Pharmacy

March 22nd 2023

Immunotherapies Changing the Way Relapsed/Refractory Settings Are Managed

March 24th 2023

On The Shelf - Career Wellness

March 16th 2023

FDA Approves Rezafungin Injection for the Treatment of Candidemia, Invasive Candidiasis

March 24th 2023

Pharmacists are Essential in Curbing the Opioid Crisis in Older People

March 24th 2023
© 2023 MJH Life Sciences

All rights reserved.